OB/GYN 2014-12 - OB/GYN Clinical Alert - Dec 01, 2014

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Editor
Jeffrey T. Jensen, MD, MPH
Leon Speroff
Professor and Vice Chair for Research
Department of Obstetrics and Gynecology
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Associate Professor
Department of OB/GYN
Oregon Health & Science University
Portland

Executive Editor
Leslie G. Coplin
AHC Media

Managing Editor
Neill L. Kimball
AHC Media

Associate Editors
Rebecca H. Allen, MD, MPH
Assistant Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Women and Infants Hospital
Providence, RI

Robert L. Coleman, MD
Professor
University of Texas M.D. Anderson Cancer Center
Houston

John C. Hobbins, MD
Professor of Obstetrics and Gynecology
University of Colorado School of Medicine
Aurora

Authors
Michael A. Thomas, MD
Professor, Reproductive Endocrinology and Infertility,
Director, Division of Reproductive Endocrinology and Infertility,
University of Cincinnati College of Medicine



Subjects:

  • Association Between Maternal Characteristics, Abnormal Serum Aneuploidy Analytes, and Placental Abruption
  • The OPTIMAL Trial: SSLF and ULS for Apical Vaginal Prolapse
  • Risk Reduction Salpingectomy for Permanent Contraception: Ready for Prime Time?
  • Tubal Sterilization: Has the Time Come for Routine Bilateral Salpingectomy?

Objectives:

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Financial Disclosure:

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, is a consultant for and on the Advisory boards of Abbvie, Agile Pharmaceuticals, Bayer,ContraMed, Evofem, HRA Pharma, Merck, and Teva; and receives grant/research support from Abbvie, Bayer,Evofem, and HRA Pharma.

Peer Reviewer Catherine LeClair, MD, Executive Editor Leslie G. Coplin, and Managing Editor Neill Kimball report no financial relationship to this field of study.

Copyright 2014, AHC Media. All rights reserved.